Stay updated with breaking news from Transformative Neuroscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
-- Observed reductions of 11% and 12% in 24- and 27-hydroxycholesterol in cerebrospinal fluid , respectively, indicating potential improvement of cholesterol metabolism in the brain -- -- Observed 8%...
Phase 2a data published in The Lancet’s eBioMedicinesupports further development of UB-311
Toronto, ON (PRWEB) June 20, 2023 -- The Global Alzheimer's Platform Foundation (GAP) is delighted to announce a collaborative, free webinar focusing on the
Broad participation at this year's congress highlights Prothena's leadership in advancing next generation treatments for Alzheimer's and Parkinson's disease Oral presentation on PRX012, Prothena's
Predicting when new drugs come to market in the United States has never been an exact science, but several drugs that could be approved in 2023 could have a significant impact on health for millions of people.